Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Return on Assets (2016 - 2025)

Historic Return on Assets for Theravance Biopharma (TBPH) over the last 12 years, with Q3 2025 value amounting to 0.05%.

  • Theravance Biopharma's Return on Assets rose 1900.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 1900.0%. This contributed to the annual value of 0.17% for FY2024, which is 600.0% down from last year.
  • According to the latest figures from Q3 2025, Theravance Biopharma's Return on Assets is 0.05%, which was up 1900.0% from 0.01% recorded in Q2 2025.
  • Theravance Biopharma's 5-year Return on Assets high stood at 1.81% for Q2 2023, and its period low was 0.49% during Q1 2021.
  • In the last 5 years, Theravance Biopharma's Return on Assets had a median value of 0.09% in 2021 and averaged 0.28%.
  • As far as peak fluctuations go, Theravance Biopharma's Return on Assets soared by 18400bps in 2022, and later plummeted by -19400bps in 2024.
  • Theravance Biopharma's Return on Assets (Quarter) stood at 0.17% in 2021, then skyrocketed by 734bps to 1.41% in 2022, then crashed by -110bps to 0.14% in 2023, then decreased by -30bps to 0.18% in 2024, then surged by 129bps to 0.05% in 2025.
  • Its last three reported values are 0.05% in Q3 2025, 0.01% for Q2 2025, and 0.19% during Q1 2025.